Jason K. Perry
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, HIV/AIDS drug development and treatment, Viral Infections and Immunology Research, COVID-19 Clinical Research Studies
Most-Cited Works
- → Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy(2004)9,716 cited
- → Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency(2020)1,006 cited
- → Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses(2017)653 cited
- → Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice(2020)537 cited
- → Structural basis for RNA replication by the hepatitis C virus polymerase(2015)346 cited
- → Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection(2013)290 cited